ZNTL
Zentalis Pharmaceuticals, Inc.Company with tickers: ZNTL
CIK
1725160
CUSIP
98943L107
Shares Outstanding
71,186,348
13F Activity (30d)
96 filings
94 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-26 | Campbell Shannon |
Director | Award | 114,200 |
| 2026-05-22 | Campbell Shannon |
Director | Other | 0 |
| 2026-02-10 | Vultaggio Vincent |
PAO and PFO | Sell | 6,894 |
| 2026-02-09 | EASTLAND JULIA MARIE |
Director, CEO & President | Sell | 889 |
| 2026-02-09 | Bruns Ingmar |
Chief Medical Officer | Sell | 335 |
| 2026-02-09 | Vultaggio Vincent |
PAO and PFO | Sell | 3,379 |
| 2026-02-06 | Vultaggio Vincent |
PAO and PFO | Sell | 29,951 |
| 2026-02-06 | EASTLAND JULIA MARIE |
Director, CEO & President | Sell | 7,866 |
| 2026-02-06 | Bruns Ingmar |
Chief Medical Officer | Sell | 2,962 |
| 2026-02-03 | Vultaggio Vincent |
PAO and PFO | Sell | 556 |
| 2026-02-02 | Vultaggio Vincent |
PAO and PFO | Sell | 2,540 |
| 2026-01-08 | Bucher James B |
EVP and General Counsel | Award | 100,000 |
| 2026-01-08 | Bruns Ingmar |
Chief Medical Officer | Award | 365,000 |
| 2026-01-08 | Vultaggio Vincent |
PAO and PFO | Award | 100,000 |
| 2026-01-08 | EASTLAND JULIA MARIE |
Director, CEO & President | Award | 775,000 |
| 2025-12-31 | WALTERS GROUP |
10% Owner | Buy | 6,459,973 |
| 2025-12-15 | Matrix Capital Management Company, LP |
10% Owner | Sell | 7,500,000 |
| 2025-12-15 | WALTERS GROUP |
10% Owner | Other | 7,050,000 |
| 2025-10-01 | Bucher James B |
EVP and General Counsel | Award | 400,000 |
| 2025-09-18 | Bucher James B |
EVP and General Counsel | Other | 0 |
| 2025-06-17 | Kariuki Enoch |
Director | Award | 57,603 |
| 2025-06-17 | Walker Luke Nathaniel |
Director | Award | 57,603 |
| 2025-06-17 | Skvarka Jan |
Director | Award | 57,603 |
| 2025-06-17 | Myers Scott Dunseth |
Director | Award | 57,603 |
| 2025-06-17 | Johnson David Michael |
Director | Award | 57,603 |
| 2025-04-30 | Myers Scott Dunseth |
Director | Buy | 21,000 |
| 2025-02-06 | Bruns Ingmar |
Chief Medical Officer | Buy | 20,000 |
| 2025-02-03 | Lackner Mark |
Chief Scientific Officer | Award | 124,714 |
| 2025-02-03 | Vultaggio Vincent |
PAO and PFO | Sell | 2,615 |
| 2025-02-03 | Vultaggio Vincent |
PAO and PFO | Award | 35,633 |
| 2025-02-03 | Vultaggio Vincent |
PAO and PFO | Award | 158,586 |
| 2025-02-03 | EASTLAND JULIA MARIE |
Director, CEO & President | Award | 59,388 |
| 2025-02-03 | Paul Andrea |
Chief Legal Officer | Sell | 13,230 |
| 2025-02-03 | Paul Andrea |
Chief Legal Officer | Award | 934,041 |
| 2025-02-03 | Bruns Ingmar |
Chief Medical Officer | Award | 16,629 |
| 2025-02-03 | Lackner Mark |
Chief Scientific Officer | Award | 335,907 |
| 2025-02-03 | EASTLAND JULIA MARIE |
Director, CEO & President | Award | 59,388 |
| 2025-02-03 | Bruns Ingmar |
Chief Medical Officer | Award | 16,629 |
| 2025-02-03 | Paul Andrea |
Chief Legal Officer | Award | 124,714 |
| 2025-02-03 | Lackner Mark |
Chief Scientific Officer | Sell | 14,368 |
| 2025-01-31 | Walker Luke Nathaniel |
Director | Buy | 14,200 |
| 2025-01-31 | Skvarka Jan |
Director | Buy | 60,000 |
| 2025-01-31 | EASTLAND JULIA MARIE |
Director, CEO & President | Buy | 28,500 |
| 2025-01-02 | Lackner Mark |
Chief Scientific Officer | Sell | 4,411 |
| 2024-12-02 | EASTLAND JULIA MARIE |
Director, CEO & President | Award | 3,028,800 |
| 2024-12-02 | Bruns Ingmar |
Chief Medical Officer | Award | 712,650 |
| 2024-11-13 | Bruns Ingmar |
Chief Medical Officer | Other | 0 |
| 2024-11-13 | Myers Scott Dunseth |
Director | Award | 260,192 |
| 2024-11-13 | Myers Scott Dunseth |
Director | Other | 0 |
| 2024-11-13 | EASTLAND JULIA MARIE |
Director, CEO & President | Other | 0 |
Showing 1–50 of 770 transactions